Document is current

Any future updates will be listed below

Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients

Crossref DOI link: https://doi.org/10.1007/s40264-015-0389-2

Published Online: 2016-01-21

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark